Background: Prophylactic human papillomavirus (HPV) vaccines are available, but uptake is
suboptimal. Information on factors influencing parental decisions regarding vaccination will …

Human papillomavirus (HPV) vaccination holds exceptional promise for preventing genital
warts, cervical cancer and other HPV-related cancers (Markowitz et al., 2007). Most research …

ABSTRACT Background/Objective: Human papillomavirus (HPV) is the most common
sexually transmitted infection in the United States. Previous research suggests some …

BACKGROUND: We assessed human papillomavirus (HPV) vaccine uptake among
adolescent girls, parents' intentions to vaccinate daughters, and barriers and facilitators of …

PURPOSE: The objective of this study was to compare the reasons why mothers do or do
not have their adolescent daughters vaccinated against HPV. METHODS: Mothers of …

Purpose Human papillomavirus (HPV) vaccination is recommended for 11-to 12-year-old
US adolescents. Unfortunately, HPV vaccine rates have been suboptimal. Parents are key …

The goal of the study was to examine the reasons given by parents who accepted or refused
the HPV vaccine for their daughters in the context of a free provincial school-based …

OBJECTIVE: The goal was to describe factors associated with human papillomavirus (HPV)
vaccination series initiation (≥ 1 dose) and completion (≥ 3 doses) and parents' intent to …

Background: Human papillomavirus (HPV) vaccine uptake is low among adolescent girls in
the United States. We sought to identify longitudinal predictors of HPV vaccine initiation in …

We performed a retrospective cohort study in a largely Latino population in Los Angeles,
surveying 95 parents of 11–17 year old girls between May and June 2008 to examine …